These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 25864417

  • 1. Evaluation of the risks of chemotherapy in dogs with thrombocytopenia.
    Finlay J, Wyatt K, Black M.
    Vet Comp Oncol; 2017 Mar; 15(1):151-162. PubMed ID: 25864417
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a manual technique for detection of neutropenia and thrombocytopenia in dogs receiving chemotherapy.
    Wyatt KM, Wyatt GL.
    J Am Vet Med Assoc; 2002 Jun 15; 220(12):1805-6. PubMed ID: 12092952
    [Abstract] [Full Text] [Related]

  • 3. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
    Heading KL, Brockley LK, Bennett PF.
    Aust Vet J; 2011 Apr 15; 89(4):109-16. PubMed ID: 21418164
    [Abstract] [Full Text] [Related]

  • 4. Carboplatin-induced myelosuppression as related to body weight in dogs.
    Coffee C, Roush JK, Higginbotham ML.
    Vet Comp Oncol; 2020 Dec 15; 18(4):804-810. PubMed ID: 32452107
    [Abstract] [Full Text] [Related]

  • 5. Adverse effects of concurrent carboplatin chemotherapy and radiation therapy in dogs.
    Hume KR, Johnson JL, Williams LE.
    J Vet Intern Med; 2009 Dec 15; 23(1):24-30. PubMed ID: 19175716
    [Abstract] [Full Text] [Related]

  • 6. Supporting the veterinary cancer patient on chemotherapy: neutropenia and gastrointestinal toxicity.
    Vail DM.
    Top Companion Anim Med; 2009 Aug 15; 24(3):122-9. PubMed ID: 19732730
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gastrointestinal toxicity after vincristine or cyclophosphamide administered with or without maropitant in dogs: a prospective randomised controlled study.
    Mason SL, Grant IA, Elliott J, Cripps P, Blackwood L.
    J Small Anim Pract; 2014 Aug 15; 55(8):391-8. PubMed ID: 24920169
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam.
    Eichstadt LR, Moore GE, Childress MO.
    Vet Comp Oncol; 2017 Dec 15; 15(4):1346-1353. PubMed ID: 27714960
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of factors associated with prolonged hospital stay and outcome of febrile neutropenic patients receiving chemotherapy: 70 cases (1997-2010).
    Britton BM, Kelleher ME, Gregor TP, Sorenmo KU.
    Vet Comp Oncol; 2014 Dec 15; 12(4):266-76. PubMed ID: 22998454
    [Abstract] [Full Text] [Related]

  • 15. Fasting reduces the incidence of vincristine-associated adverse events in dogs.
    Duckett ME, Curran KM, Leeper HJ, Ruby CE, Bracha S.
    Vet Comp Oncol; 2021 Mar 15; 19(1):61-68. PubMed ID: 33448618
    [Abstract] [Full Text] [Related]

  • 16. Toxicity associated with epirubicin treatments in a large case series of dogs.
    Marrington AM, Killick DR, Grant IA, Blackwood L.
    Vet Comp Oncol; 2012 Jun 15; 10(2):113-23. PubMed ID: 22236353
    [Abstract] [Full Text] [Related]

  • 17. A prospective study of the association of anemia and thrombocytopenia with ocular lesions in dogs.
    Shelah-Goraly M, Aroch I, Kass PH, Bruchim Y, Ofri R.
    Vet J; 2009 Nov 15; 182(2):187-92. PubMed ID: 18664411
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.